Akebia Therapeutics Inc. Common Stock is a biopharmaceutical company that focuses on the development and commercialization of therapeutics for patients with kidney disease. With a strong pipeline and strategic collaborations, the company is dedicated to improving the lives of those affected by this debilitating condition.
Notification